Literature DB >> 30518804

Prognostic role of masked and white-coat hypertension: 10-Year mortality in treated elderly hypertensives.

Francesco Spannella1,2, Andrea Filipponi1,2, Federico Giulietti1,2, Paolo Balietti1,2, Beatrice Bernardi1,2, Giulia Rosettani1,2, Riccardo Sarzani3,4.   

Abstract

White-coat uncontrolled hypertension (WUCH) and masked uncontrolled hypertension (MUCH) are common in the elderly. The prognostic role of these hypertension phenotypes is not completely defined in this subpopulation. Our aim is to evaluate the long-term prognostic role of WUCH and MUCH in treated elderly hypertensives. Observational study conducted on 120 consecutive treated elderly hypertensives. Patients were assessed on a first clinical visit in 2006. Subsequently, such patients or their relatives have been recalled after 10 years to evaluate the survival rates. Main inclusion criteria at baseline: age ≥ 65 years, a previous diagnosis of essential hypertension, a valid 24-h ambulatory blood pressure monitoring (ABPM). All participants received anti-hypertensive drugs during the 10-year period and we considered 10-year mortality for the analysis. General characteristics at baseline: mean age was 71.2 ± 5.3 years; females were 53.3%; 15.1% of patients had sustained controlled hypertension (SCH), 35.8% had WUCH, 10.8% had MUCH and 38.3% had sustained uncontrolled hypertension (SUCH). Thirty-two patients (26.7%) died during the 10-year period. Deceased patients were older, had lower treatment intensity, HDLc levels and eGFR than survivors. After adjusting for these covariates, MUCH (HR 12.30, p < 0.001) and SUCH (HR 4.84, p = 0.007) were associated with higher risk of death, compared to SCH, while no relationship emerged with WUCH (HR 1.58, p = 0.455). In our real-life study on treated elderly hypertensives, MUCH was associated with higher risk of death, compared to SCH and SUCH, while WUCH was not. ABPM is a key tool to improve management and therefore prognosis in this subpopulation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30518804     DOI: 10.1038/s41371-018-0140-4

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Self-Monitoring Home Blood Pressure in Community-Dwelling Older People: Age Differences in White-Coat and Masked Phenomena and Related Factors-The SONIC Study.

Authors:  Jinmei Tuo; Kayo Godai; Mai Kabayama; Yuya Akagi; Hiroshi Akasaka; Yoichi Takami; Yasushi Takeya; Koichi Yamamoto; Ken Sugimoto; Saori Yasumoto; Yukie Masui; Yasumichi Arai; Kazunori Ikebe; Yasuyuki Gondo; Tatsuro Ishizaki; Hiromi Rakugi; Kei Kamide
Journal:  Int J Hypertens       Date:  2022-04-30       Impact factor: 2.434

Review 2.  A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective.

Authors:  Jinho Shin; Kwang-Il Kim
Journal:  Clin Hypertens       Date:  2022-06-15

3.  Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/Obese.

Authors:  Francesco Spannella; Federico Giulietti; Chiara Di Pentima; Riccardo Sarzani
Journal:  Adv Ther       Date:  2019-04-05       Impact factor: 3.845

4.  The Number of Pills, Rather Than the Type of Renin-Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study.

Authors:  Riccardo Sarzani; Federico Giulietti; Andrea Filipponi; Sonia Marziali; Letizia Ristori; Silvia Buscarini; Caterina Garbuglia; Simone Biondini; Massimiliano Allevi; Francesco Spannella
Journal:  Adv Ther       Date:  2021-06-11       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.